Emergent BioSolutions reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Akebia Therapeutics 0 0 Mar/2025
Coherus Biosciences 0 0 Mar/2025
Emergent BioSolutions 0 0 Mar/2025
Glaxosmithkline GBP 1.88 2.59 Sep/2026
Heron Therapeutics 0 0 Mar/2025
Lexicon Pharmaceuticals 0 0 Mar/2025
Lonza 0.74 0.04 Dec/2025
Merck 2.34 0.28 Sep/2026
Nektar Therapeutics 0 0 Mar/2025
Pfizer 6 1.08 Sep/2026
Sanofi 5.67 0.18 Sep/2026
Vanda Pharmaceuticals 0 0 Mar/2025